Ph.D. Degree Program
Application Deadline for Fall 2020 Admission: January 10, 2020
Go to Admissions page.
The Pharmaceutical Health Outcomes and Policy (PHOP) doctoral degree program at the University of Houston College of Pharmacy offers a learning and research environment that combines the collaborative opportunities of the Texas Medical Center’s world-class healthcare and scientific community with the academic resources and award-winning faculty at Houston’s only Carnegie Institute-designated Tier One public research university.
Pharmaceutical Health Outcomes and Policy consists of pharmaceutical practice and policy research, a multidisciplinary field that examines cost, access, and quality of pharmaceutical care from clinical, sociobehavioral, economic, organizational and technological perspectives.
Traditional and innovative areas of pharmaceutical health outcomes research include pharmacoepidemiology, pharmacoeconomics, comparative effectiveness research, patient-centered outcomes research, and translational research.
The Ph.D. in Pharmaceutical Health Outcomes and Policy requires the completion of a minimum number of 70 credit hours.
Almost all of our students (international and domestic) are awarded stipends from Research or Teaching Assistantships, and are reimbursed for all tuition and fees. Please see the Financial Aid section for more details.
Download Ph.D. in Pharmaceutical Health Outcomes and Policy program flier (.pdf)
For additional details about the program, visit the PHOP PhD page here.
For program admissions information, visit the PhD Graduate Admissions page here.
Recent PHOP News
ISPOR 2019 Student & Faculty Presentations (.pdf)
4 PHOP Students Earn Travel Awards to Present at ISPOR 2019
Thornton, Premier Center Receives $3.34M Grant for Prescription Misuse Prevention
Medication Safety Symposium Highlights Deprescribing, Monitoring Programs
Aparasu Receives Fulbright Specialist Assignment to Indonesian University
Inside Outcomes Newsletter 2019 (.pdf)
Ph.D. Students Earn Internships in Pharmaceutical/Health Care Industry, Government
PHOP Graduate, Candidate Among 'Best Poster' Finalists at ISPOR
ISPOR Student & Faculty Presentations (.pdf)
Houston Medication Safety Symposium Program (.pdf)
Multidisciplinary Researchers, Practitioners Discuss Opioids, Medication Burden at Symposium
Alumnus Claims Top Abstract Medal, Podium Presentation Invite at AMCP Meeting
Inside Outcomes Newsletter 2018 (.pdf)
UHCOP Team Wins Historic Repeat Win in ISPOR Student Research Competition
PHOP Student, Faculty and Alumni Presentations at ISPOR 2017 Boston (.pdf)
Research Presentations Recognized at Houston Medication Safety Symposium
April 28 Houston Medication Safety Symposium Tackles Opioid Abuse, High Risk Drugs in Older Adults
Study of Prescription Drug Monitoring Program Suggests Abuse Going Underreported
Research Team Earns $207K Grant for Study of Anticoagulants, Antiarrhythmia Drugs in Afib
PHOP Alumna Ferries Wins Humana's Jim Bloem Award
PHOP Research on Parental Stress Among ISPOR European Congress Poster Finalists
Inside Outcomes PHOP Newsletter Summer 2016 (.pdf)
Sanofi Backs Fleming's Prescriber Webinar to Boost Statin Guidelines Adoption, Adherence
Regeneron Funds Abughosh Study on Motivational Interviewing, Statin Adherence
Graduate Students Land Internships in Pharmaceutical, Consulting Sectors
PHOP Team Takes Research Competition Trophy at ISPOR International Meeting
4 PHOP Projects Among ISPOR Research Posters Finalists
PHOP Presentations at ISPOR Interational Meeting 2016 (.pdf)
PHOP Doctoral Candidate Inducted into Phi Kappa Phi Honor Society
Project on COPD Patients in Medicare Gap Strikes Gold at AMCP Meeting
Aparasu Tapped for Fulbright Specialist Roster
(PDF links requires Adobe Reader; click here for free download.)